News
1d
New Vision on MSNUS may revise hormone replacement therapy warnings
FDA Commissioner open to revising HRT warning labels due to benefits beyond menopausal symptoms, despite past breast cancer ...
CMS released the 2026 proposed payment rule for hospital outpatient departments and ASCs on July 15. The agency proposed removing 285 mostly musculoskeletal procedure codes from the inpatient-only ...
Tibial tubercle avulsion fractures (TTAFs) are uncommon but increasingly observed injuries in young athletes, especially ...
In a new study published in JAMA casting has been found by researchers to be as effective as surgery in the treatment of ...
Ultragenyx's high burn rate, costly R&D, and recent setbacks increase dilution risk, impacting future profitability. Learn ...
A Singapore doctor from International Orthopaedic Clinic shares how vertebroplasty can help bring relief to those with compression fractures.
New data shows no increased cardiovascular risk of the osteoporosis drug vs anabolic agents — and even suggests a lower risk.
Gainesville, Flordia Friday, July 11, 2025, 13:00 Hrs [IST] ...
11d
Zacks.com on MSNRARE, MREO Fall as Osteogenesis Study Likely to Continue Till Year End
Ultragenyx Pharmaceutical and Mereo BioPharma shares tumble as investors await key phase III UX143 osteogenesis data now set for release at year-end.
Discover how new physician assistant graduates navigate the transition from textbook medicine to clinical reality.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results